NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
出版年份 2016 全文链接
标题
NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
作者
关键词
Melanoma cells, Melanomas, Melanocytes, Small interfering RNAs, Immunoblotting, Fibroblasts, Non-small cell lung cancer, RNA extraction
出版物
PLoS One
Volume 11, Issue 4, Pages e0153181
出版商
Public Library of Science (PLoS)
发表日期
2016-04-06
DOI
10.1371/journal.pone.0153181
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NRF2 and p53: Januses in cancer?
- (2015) Barak Rotblat et al. Oncotarget
- NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
- (2015) Tatsuhiro Shibata et al. NEOPLASIA
- Local Melatoninergic System as the Protector of Skin Integrity
- (2014) Andrzej Slominski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemotherapy induced DNA damage response
- (2013) Derek Woods et al. CANCER BIOLOGY & THERAPY
- A Somatic Mutation of the KEAP1 Gene in Malignant Melanoma Is Involved in Aberrant NRF2 Activation and an Increase in Intrinsic Drug Resistance
- (2013) Shinpei Miura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
- (2012) Holly K. Bryan et al. BIOCHEMICAL PHARMACOLOGY
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- The transcription factor NF-E2-related Factor 2 (Nrf2): a protooncogene?
- (2012) Phillip Shelton et al. FASEB JOURNAL
- Heat shock protein 90 (HSP90 ), a substrate and chaperone of DNA-PK necessary for the apoptotic response
- (2012) S. Solier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
- (2011) Xiangyi Lu et al. BIOCHEMICAL PHARMACOLOGY
- NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
- (2011) David Siegel et al. BIOCHEMICAL PHARMACOLOGY
- A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors
- (2011) Gopa Iyer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
- (2011) Keiko Taguchi et al. GENES TO CELLS
- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
- (2011) Adam Lister et al. Molecular Cancer
- L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions
- (2011) Andrzej Slominski et al. Pigment Cell & Melanoma Research
- Ionizing Radiation Activates the Nrf2 Antioxidant Response
- (2010) J. T. McDonald et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin
- (2010) U. N. Vaishampayan et al. CLINICAL CANCER RESEARCH
- A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
- (2010) Simon Pacey et al. INVESTIGATIONAL NEW DRUGS
- Silencing HSF1 by short hairpin RNA decreases cell proliferation and enhances sensitivity to hyperthermia in human melanoma cell lines
- (2010) Yoshitaka Nakamura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Impact of NAD(P)H:Quinone Oxidoreductase-1 on Pigmentation
- (2009) Tae-Young Choi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells
- (2009) Shigeo Ohba et al. JOURNAL OF NEUROSURGERY
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma
- (2008) D. Faingold et al. CLINICAL CANCER RESEARCH
- BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors
- (2008) U. Banerji et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin abrogates the geldanamycin-induced heat shock response
- (2008) Andrea K. McCollum et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now